SLX4IP: A Protein Interaction and Potential Drug Target for Pain and Cancer

Target Name: SLX4IP

NCBI ID: G128710

SLX4IP

SLX4IP: A Protein Interaction and Potential Drug Target for Pain and Cancer

SLX4IP (SLX4-interacting protein) is a protein that is expressed in various tissues and cells throughout the body. It is a member of the SLX family of proteins, which are known for their role in cell signaling and gene regulation. SLX4IP is unique due to its ability to interact with other proteins, including SLX4, which is a key regulator of the SLX gene.

The SLX gene is located on chromosome 16 and encodes for a protein that plays a role in the development and maintenance of stem cells. SLX4 is a key regulator of the SLX gene and is known for its ability to induce the stem cell state. SLX4IP is a protein that has been shown to interact with SLX4 and is thought to play a role in the regulation of stem cell proliferation.

SLX4IP is a 21-kDa protein that is expressed in various tissues and cells, including the brain, heart, and gastrointestinal tract. It is primarily localized to the endoplasmic reticulum (ER) and is thought to play a role in the regulation of protein synthesis and degradation. SLX4IP is also known to interact with the protein known as TRPV4, which is a receptor for pain signals.

SLX4IP has been shown to play a role in the regulation of pain signaling in the brain. It is thought to interact with TRPV4 and to be involved in the regulation of pain signaling. This suggests that SLX4IP may be a potential drug target for the treatment of chronic pain.

In addition to its role in pain signaling, SLX4IP is also involved in the regulation of stem cell proliferation. It is known to interact with SLX4 and to play a role in the regulation of stem cell proliferation. This suggests that SLX4IP may be a potential biomarker for the treatment of cancer.

SLX4IP is also a protein that has been shown to interact with the protein known as SIRT1. SIRT1 is a NAD+-dependent protein that is involved in a variety of cellular processes, including DNA repair and stress resistance. SLX4IP is thought to interact with SIRT1 and to play a role in the regulation of cellular processes.

In conclusion, SLX4IP is a protein that is expressed in various tissues and cells throughout the body. It is a member of the SLX family of proteins and is known for its ability to interact with other proteins, including SLX4 and SIRT1. SLX4IP is thought to play a role in the regulation of stem cell proliferation and pain signaling in the brain. It is also a potential drug target for the treatment of chronic pain and may be a biomarker for the treatment of cancer. Further research is needed to fully understand the role of SLX4IP in cellular processes and its potential as a drug target.

Protein Name: SLX4 Interacting Protein

The "SLX4IP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLX4IP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets